Tue, Mar 4, 8:20 PM (53 days ago)
For the quarter ended January 31, 2025, Donaldson Company, Inc. (DCI) reported net sales of $870.0 million, a slight decline of 0.8% from $876.7 million in the same quarter last year. This decrease was attributed to lower sales in the Mobile Solutions and Industrial Solutions segments, partially offset by a 9.2% increase in the Life Sciences segment. Gross profit margin remained stable at 35.2%. Net earnings decreased to $95.9 million, or $0.79 per diluted share, compared to $98.7 million, or $0.81 per diluted share in the prior year. Operating income for the quarter was $125.5 million, reflecting a slight decrease from $129.7 million. Cash flow from operations totaled $163.3 million, down from $225.0 million, primarily due to increased working capital needs. The company incurred $115.1 million in investing activities, mainly for an equity investment in Medica, while financing activities used $88.5 million, a decrease from $171.7 million last year. Total debt increased to $539.7 million, representing 27.2% of total capitalization. The company remains compliant with its financial covenants and maintains a strong liquidity position with $189.1 million in cash and $347.0 million available under its credit facility. Future operations may be impacted by ongoing global economic conditions and currency fluctuations.